Medpace (MEDP) is down -24.5%, or -$124.52 to $383.94.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MEDP:
- Balancing Strong Execution With Emerging Growth Risks: Rationale for Maintaining a Hold on Medpace
- Closing Bell Movers: Tesla reverses post-earnings gains, IBM slips after Q1
- Medpace Announces Strong Q1 Results Amid Leadership Transition
- Medpace reports Q1 EPS $4.28, consensus $3.96
- Medpace affirms FY26 EPS view of $16.68-$17.50, consensus $17.35